Botanical Drug Extracts Combined With Biomaterial Carriers for Osteoarthritis Cartilage Degeneration Treatment: A Review of 10 Years of Research
- PMID: 35173609
- PMCID: PMC8841352
- DOI: 10.3389/fphar.2021.789311
Botanical Drug Extracts Combined With Biomaterial Carriers for Osteoarthritis Cartilage Degeneration Treatment: A Review of 10 Years of Research
Abstract
Osteoarthritis (OA) is a long-term chronic arthrosis disease which is usually characterized by pain, swelling, joint stiffness, reduced range of motion, and other clinical manifestations and even results in disability in severe cases. The main pathological manifestation of OA is the degeneration of cartilage. However, due to the special physiological structure of the cartilage, once damaged, it is unable to repair itself, which is one of the challenges of treating OA clinically. Abundant studies have reported the application of cartilage tissue engineering in OA cartilage repair. Among them, cell combined with biological carrier implantation has unique advantages. However, cell senescence, death and dedifferentiation are some problems when cultured in vitro. Botanical drug remedies for OA have a long history in many countries in Asia. In fact, botanical drug extracts (BDEs) have great potential in anti-inflammatory, antioxidant, antiaging, and other properties, and many studies have confirmed their effects. BDEs combined with cartilage tissue engineering has attracted increasing attention in recent years. In this review, we will explain in detail how cartilage tissue engineering materials and BDEs play a role in cartilage repair, as well as the current research status.
Keywords: biomaterial carriers; botanical drug; cartilage; extracts; osteoarthritis; tissue engineering.
Copyright © 2022 Mu, Feng, Hu, Xiong, Ma and Tian.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
The dual character of exosomes in osteoarthritis: Antagonists and therapeutic agents.Acta Biomater. 2020 Mar 15;105:15-25. doi: 10.1016/j.actbio.2020.01.040. Epub 2020 Feb 6. Acta Biomater. 2020. PMID: 32006653 Review.
-
Mesenchymal Stem Cells for Cartilage Regeneration of TMJ Osteoarthritis.Stem Cells Int. 2017;2017:5979741. doi: 10.1155/2017/5979741. Epub 2017 Oct 16. Stem Cells Int. 2017. PMID: 29123550 Free PMC article. Review.
-
Tannic acid/Sr2+-coated silk/graphene oxide-based meniscus scaffold with anti-inflammatory and anti-ROS functions for cartilage protection and delaying osteoarthritis.Acta Biomater. 2021 May;126:119-131. doi: 10.1016/j.actbio.2021.02.046. Epub 2021 Mar 5. Acta Biomater. 2021. PMID: 33684536
-
A human osteoarthritis osteochondral organ culture model for cartilage tissue engineering.Biomaterials. 2018 Apr;162:1-21. doi: 10.1016/j.biomaterials.2018.02.002. Epub 2018 Feb 4. Biomaterials. 2018. PMID: 29428675
-
A Comprehensive Review of Stem Cells for Cartilage Regeneration in Osteoarthritis.Adv Exp Med Biol. 2018;1089:23-36. doi: 10.1007/5584_2018_205. Adv Exp Med Biol. 2018. PMID: 29725971 Review.
Cited by
-
Network Pharmacology-Based Strategy to Investigate the Mechanisms of Cibotium barometz in Treating Osteoarthritis.Evid Based Complement Alternat Med. 2022 Jul 14;2022:1826299. doi: 10.1155/2022/1826299. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35873632 Free PMC article.
-
Phytochemical Compounds Involved in the Bone Regeneration Process and Their Innovative Administration: A Systematic Review.Plants (Basel). 2023 May 22;12(10):2055. doi: 10.3390/plants12102055. Plants (Basel). 2023. PMID: 37653972 Free PMC article. Review.
-
A Bibliometric and Knowledge Map Analysis of Osteoarthritis Signaling Pathways from 2012 to 2022.J Pain Res. 2022 Dec 6;15:3833-3846. doi: 10.2147/JPR.S385482. eCollection 2022. J Pain Res. 2022. PMID: 36510617 Free PMC article.
-
Edge advances in nanodrug therapies for osteoarthritis treatment.Front Pharmacol. 2024 Oct 30;15:1402825. doi: 10.3389/fphar.2024.1402825. eCollection 2024. Front Pharmacol. 2024. PMID: 39539625 Free PMC article. Review.
-
Ginkgolide C slows the progression of osteoarthritis by activating Nrf2/HO-1 and blocking the NF-κB pathway.Front Pharmacol. 2022 Oct 28;13:1027553. doi: 10.3389/fphar.2022.1027553. eCollection 2022. Front Pharmacol. 2022. PMID: 36386227 Free PMC article.
References
-
- Ahmed S., Rahman A., Hasnain A., Lalonde M., Goldberg V. M., Haqqi T. M. (2002). Green tea Polyphenol Epigallocatechin-3-Gallate Inhibits the IL-1 Beta-Induced Activity and Expression of Cyclooxygenase-2 and Nitric Oxide Synthase-2 in Human Chondrocytes. Free Radic. Biol. Med. 33 (8), 1097–1105. 10.1016/s0891-5849(02)01004-3 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources